Market Cap 75.56B
Revenue (ttm) 40.10B
Net Income (ttm) 3.29B
EPS (ttm) N/A
PE Ratio 9.04
Forward PE 8.24
Profit Margin 8.21%
Debt to Equity Ratio 1.35
Volume 5,084,100
Avg Vol 5,602,526
Day's Range N/A - N/A
Shares Out 2.06B
Stochastic %K 5%
Beta 0.51
Analysts Sell
Price Target $41.22

Latest News on GSK

ITeos, GSK discontinue lung cancer therapy development

May 13, 2025, 8:21 AM EDT - 13 hours ago

ITeos, GSK discontinue lung cancer therapy development


New vaccine chief rocks pharmaceutical stocks

May 7, 2025, 11:13 AM EDT - 6 days ago

New vaccine chief rocks pharmaceutical stocks

BNTX MRNA NVAX PFE IBB SRPT XBI


5 Reasons GSK Looks Good

May 5, 2025, 11:37 AM EDT - 8 days ago

5 Reasons GSK Looks Good


GSK plc (GSK) Q1 2025 Earnings Conference Call Transcript

Apr 30, 2025, 12:32 PM EDT - 13 days ago

GSK plc (GSK) Q1 2025 Earnings Conference Call Transcript


GSK Sales, Profit Rise on Boost from Cancer Drugs

Apr 30, 2025, 2:27 AM EDT - 13 days ago

GSK Sales, Profit Rise on Boost from Cancer Drugs


Pharma firms maastraz

Apr 29, 2025, 12:06 PM EDT - 14 days ago

Pharma firms maastraz

AZN NVO NVS


GSK resolves patent lawsuit against Pfizer over RSV vaccines

Apr 3, 2025, 6:03 PM EDT - 5 weeks ago

GSK resolves patent lawsuit against Pfizer over RSV vaccines

PFE